Inhibitors of interleukin-2 inducible T-cell kinase as potential therapeutic candidates for the treatment of various inflammatory disease conditions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibitors of interleukin-2 inducible T-cell kinase as potential therapeutic candidates for the treatment of various inflammatory disease conditions

Published:2012-10 Issue:3 Volume:47 Page:574-588
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Kaur Maninder,Bahia Malkeet Singh,Silakari Om

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference82 articles.

1. Molecular Biology of Cell;Alberts,2002

2. Protein kinase C-θ (PKCθ): it’s all about location, location, location;Altman;Immunol. Rev.,2003

3. Astrazeneca AB. Substituted pyrrolopyridines. WO2004016610, US20050266331.

4. Astrazeneca AB. Use of and some novel imidazopyridine. WO2004016611, US2005026133.

5. Astrazeneca AB. Novel use of benzothiazole derivatives. WO2004016600, US20060106015.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dihydroartemisinin inhibits follicular helper T and B cells: implications for systemic lupus erythematosus treatment;Archives of Pharmacal Research;2024-07

2. The Application of Pyrrolo[2, 3-d]pyrimidine Scaffold in Medicinal Chemistry from 2017 to 2021;Mini-Reviews in Medicinal Chemistry;2023-06

3. Identification of IL-2 inducible tyrosine kinase inhibitors by quantum mechanics and ligand based virtual screening approaches;Journal of Biomolecular Structure and Dynamics;2023-05-22

4. The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study;Journal of Translational Medicine;2023-04-17

5. Discovery of Potent and Highly Selective Interleukin-2-Inducible T-Cell Kinase Degraders with In Vivo Activity;Journal of Medicinal Chemistry;2023-03-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3